PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer

BACKGROUND: The expression of programmed death (PD) ligand 1 (PD-L1) protein expression assessed by immunohistochemistry (IHC) has been correlated with response and survival benefit from anti-PD-1/PD-L1 immune checkpoint inhibitor therapies in advanced non-small cell lung carcinoma (NSCLC). The effi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ann Oncol
Glavni autori: Tsao, M.-S., Le Teuff, G., Shepherd, F. A., Landais, C., Hainaut, P., Filipits, M., Pirker, R., Le Chevalier, T., Graziano, S., Kratze, R., Soria, J.-C., Pignon, J.-P., Seymour, L., Brambilla, E.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2017
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5834092/
https://ncbi.nlm.nih.gov/pubmed/28137741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdx003
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items